Home›Compare›Embody vs Raeliva

Embody vs Raeliva: Which Is Better?

Head-to-head comparison of Embody and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 54.9/100), leading on trust & safety, value, experience, reputation. Embody comes out ahead on product range. Embody has the lower entry price (from $69/mo vs $117/mo), so the better value depends on which treatment you need.

55
Embody
Below Average

Embody (joinem.co) is a low-price compounded GLP-1 storefront launched in late 2025 that also sells sermorelin and NAD+. It carries a BBB F rating and a high share of 1-star reviews.

Visit Embody
61

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

DimensionEmbodyRaeliva
Overall Score54.9/10061.2/100 ✓
Trust & Safety30%48/10060/100 ✓
Value25%68/10072/100 ✓
Experience20%50/10062/100 ✓
Product Range15%62/100 ✓55/100
Reputation10%42/10045/100 ✓

At a Glance

Founded20252026
HeadquartersWilmington, DESan Diego, CA
Publicly tradedNoNo
Treatment categories22
Treatments listed47
Starting price$69/mo$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryEmbodyRaeliva
Weight Loss / GLP-1$69–$199
Compounded Semaglutide
$150–$219
Compounded Semaglutide Injections
Longevity & Peptides$99–$199
NAD+ Injection or Nasal Spray
$117–$179
NAD+

Embody

+Among the lowest advertised compounded GLP-1 prices: semaglutide from $79/mo, tirzepatide from $129/mo month-to-month
+Names its clinical network (OpenLoop Health) and four dispensing pharmacies
+Dose increases do not raise the price within a plan; HSA/FSA accepted
−BBB rating F (not accredited) for failing to respond to 23 complaints as of August 2026
−24% of ~8,600 Trustpilot reviews are 1-star, citing shipping delays, auto-renewal charges and refund difficulty
−Advertised landing-page prices conflict with the published terms ($79 vs $199/mo semaglutide; a $99-then-$299 starter plan)
Read the full Embody review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies
+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page
+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible
−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months
−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable
−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts
Read the full Raeliva review →

Embody vs Raeliva — FAQ

Is Embody better than Raeliva?

▾

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 54.9/100), leading on trust & safety, value, experience, reputation. Embody comes out ahead on product range. Embody has the lower entry price (from $69/mo vs $117/mo), so the better value depends on which treatment you need.

Is Embody or Raeliva cheaper?

▾

Embody has the lower starting price (from $69/mo vs $117/mo for Raeliva). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Embody and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1, Longevity & Peptides. Embody covers 2 treatment categories total and Raeliva covers 2.

Still deciding?